Bezlotoxumab is a fully humanized IgG1 kappa monoclonal antibody that binds to and neutralizes Clostridium difficile toxin B, used to reduce C. difficile infection recurrence. The DrugMonitor™ Anti-Bezlotoxumab Antibody (VS-1224-YC191) is an anti-drug antibody (ADA) against Bezlotoxumab. This drug-based antibody is raised in mice immunized with the Bezlotoxumab. The anti-Bezlotoxumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Bezlotoxumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-C. Diff Toxin B Recombinant Antibody (Bezlotoxumab)Recombinant human monoclonal antibody expressed in CHO binding to toxin B [C. difficile]. Bezlotoxumab is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection.
Afuco™ Anti-C. difficile toxin B ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-725)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human monoclonal antibody expressed in CHO binding to toxin B [C. difficile]. It is a human monoclonal antibody designed for the prevention of recurrence of Clostridium difficile infection.
There are currently no Customer reviews or questions for VS-1224-YC191. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.